1.
|
17 p, 3.1 MB |
Effects of a carob-pod-derived sweetener on glucose metabolism
/
Lambert, Carmen (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Cubedo, Judit (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ;
Padró, Teresa (Institut d'Investigació Biomèdica Sant Pau) ;
Vilahur, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
López-Bernal, Sergi (Institut d'Investigació Biomèdica Sant Pau) ;
Rocha, Milagros (Hospital Universitari Dr Peset) ;
Hernández-Mijares, Antonio (Universitat de València) ;
Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Patients with type 2 diabetes mellitus (T2DM) have a higher incidence of cardiovascular (CV) events. The ingestion of high-glycemic index (GI) diets, specially sweetened beverage consumption, has been associated with the development of T2DM and CV disease. [...]
2018 - 10.3390/nu10030271
Nutrients, Vol. 10 Núm. 3 (march 2018) , p. 271
|
|
2.
|
8 p, 594.7 KB |
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes : Achieving HbA1c targets with basal insulin in a real-world setting
/
Meneghini, Luigi F. (Parkland Health & Hospital System) ;
Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ;
Orsi, Emanuela (Fondazione Ca' Granda IRCCS) ;
Lalic, Nebojsa M. (University of Belgrade) ;
Cali, Anna M.G. (Sanofi) ;
Westerbacka, Jukka (Sanofi) ;
Stella, Peter (Sanofi) ;
Candelas, Christophe (Sanofi) ;
Pilorget, Valerie (Sanofi) ;
Perfetti, Riccardo (Sanofi) ;
Khunti, Kamlesh (University of Leicester) ;
Universitat Autònoma de Barcelona
To describe in a real-world setting the achievement of physician-selected individualized HbA1c targets in individuals with type 2 diabetes, newly or recently initiated with basal insulin, and the association of hypoglycaemia with target achievement. [...]
2019 - 10.1111/dom.13673
Diabetes, Obesity and Metabolism, Vol. 21 Núm. 6 (june 2019) , p. 1429-1436
|
|
3.
|
12 p, 1.0 MB |
The importance of the initial period of basal insulin titration in people with diabetes
/
Khunti, Kamlesh (University of Leicester) ;
Giorgino, F. (University of Bari Aldo Moro) ;
Berard, L. (Winnipeg Regional Health Authority) ;
Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ;
Harris, S.B. (Western University) ;
Universitat Autònoma de Barcelona
Achieving target glycaemic control is essential in people with diabetes to minimize the risk of long-term complications, and many people with type 2 diabetes will ultimately require basal insulin (BI) therapy to achieve their individualized glycaemic targets. [...]
2020 - 10.1111/dom.13946
Diabetes, Obesity and Metabolism, Vol. 22 Núm. 5 (january 2020) , p. 722-733
|
|
4.
|
13 p, 1.6 MB |
Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus
/
Freemantle, Nick (University College London) ;
Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ;
Giaccari, A. (Università Cattolica del Sacro Cuore) ;
Bailey, T. (AMCR Institute) ;
Roussel, R. (UFR de Médecine. Paris University) ;
Franco, D. (CPCLIN Clinical Research Center) ;
Berthou, B. (IT&M Stats) ;
Pilorget, V. (Sanofi) ;
Westerbacka, J. (Sanofi) ;
Bosnyak, Z. (Sanofi) ;
Bonnemaire, Mireille (Sanofi) ;
Cali, Anna M.G (Sanofi) ;
Nguyên-Pascal, M.L. (Sanofi) ;
Penfornis, A. (Corbeil-Essonnes and Université Paris Sud) ;
Perez-Maraver, Manuel (Hospital Universitari de Bellvitge) ;
Seufert, J. (University of Freiburg) ;
Sullivan, S.D. (University of Washington) ;
Wilding, J. (University of Liverpool) ;
Wysham, C. (Multicare Rockwood Clinic) ;
Davies, M. (University of Leicester) ;
Universitat Autònoma de Barcelona
To compare real-world outcomes with newer (insulin glargine 300 U/mL; Gla-300) versus standard of care (SoC) basal insulins (BIs) in the REACH (insulin-naïve; NCT02967224) and REGAIN (basal insulin-treated; NCT02967211) studies in participants with uncontrolled type 2 diabetes (T2DM) in Europe and Brazil. [...]
2020 - 10.1080/03007995.2019.1708287
Current Medical Research and Opinion, Vol. 36 Núm. 4 (february 2020) , p. 571-581
|
|
5.
|
8 p, 533.2 KB |
Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes : Protocol of REALI project
/
Freemantle, N. (University College London) ;
Bonadonna, Riccardo C (University of Parma) ;
Gourdy, P. (Paul Sabatier University) ;
Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ;
Mueller-Wieland, D. (University Hospital Aachen (Alemanya)) ;
Bigot, Gregory (IVIDATA) ;
Ciocca, A. (Sanofi SA) ;
Mauquoi, C. (IDDI SA) ;
Rollot, M. (Quinten) ;
Bonnemaire, Mireille (Sanofi SA) ;
Universitat Autònoma de Barcelona
Type 2 diabetes mellitus (T2DM) is a common and heterogeneous disease. Using advanced analytic approaches to explore real-world data may identify different disease characteristics, responses to treatment and progression patterns. [...]
2020 - 10.1136/bmjopen-2019-033659
BMJ open, Vol. 10 Núm. 4 (28 2020) , p. 201903365
|
|
6.
|
|
7.
|
|
8.
|
17 p, 389.2 KB |
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
/
Gourdy, Pierre (Université de Toulouse) ;
Bonadonna, Riccardo C. (University of Parma) ;
Freemantle, Nick (University College London) ;
Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ;
Müller-Wieland, Dirk (University Hospital Aachen (Alemanya)) ;
Bigot, Gregory (IVIDATA) ;
Mauquoi, Celine (IDDI) ;
Ciocca, Alice (General Medicines. Sanofi) ;
Bonnemaire, Mireille (General Medicines. Sanofi)
Introduction: Gender differences in risk factors and treatment outcomes for type 2 diabetes mellitus (T2DM) may exist. We used the REALI European database to investigate whether there were gender-specific differences in baseline characteristics and clinical outcomes among patients with inadequately controlled T2DM initiated on insulin glargine 300 U/ml (Gla-300). [...]
2022 - 10.1007/s13300-021-01179-8
Diabetes Therapy, Vol. 13 Núm. 1 (january 2022) , p. 57-73
|
|
9.
|
14 p, 4.1 MB |
Targeting cholesteryl ester accumulation in the heart improves cardiac insulin response
/
Actis Dato, Virginia (Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI)) ;
Benitez Amaro, Aleyda (Institut d'Investigació Biomèdica Sant Pau) ;
García Rodríguez, Jesús Eduardo (Institut d'Investigació Biomèdica Sant Pau) ;
Claudi, Lene (Institut d'Investigació Biomèdica Sant Pau) ;
La Chica, María Teresa (Institut d'Investigació Biomèdica Sant Pau) ;
Iborra, A. (Universitat Autònoma de Barcelona) ;
Escolà-Gil, Joan Carles (Institut d'Investigació Biomèdica Sant Pau) ;
Guerra Ramos, José María (Institut d'Investigació Biomèdica Sant Pau) ;
Samouillan, V. (CIRIMAT. Université de Toulouse. Université Paul Sabatier. Equipe PHYPOL) ;
Enrich, C. (Centre de Recerca Biomèdica CELLEX. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ;
Chiabrando, G.A (Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI)) ;
Llorente-Cortés, Vicenta (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Background: Antibodies against the P3 sequence (Gly1127-Cys1140) of LRP1 (anti-P3 Abs) specifically block cholesteryl ester (CE) accumulation in vascular cells. LRP1 is a key regulator of insulin receptor (InsR) trafficking in different cell types. [...]
2022 - 10.1016/j.biopha.2022.113270
Biomedicine & pharmacotherapy, Vol. 152 (august 2022) , p. 113270
|
|
10.
|
10 p, 635.4 KB |
Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain
/
Biagetti, Betina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Iglesias, Pedro (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Villar-Taibo, Rocío (Instituto de Investigación Sanitaria de Santiago (IDIS)) ;
Moure, Maria-Dolores (Instituto de Investigación Sanitaria de Santiago (IDIS)) ;
Paja, Miguel (Hospital de Basurto (Bilbao, Biscaia)) ;
Araujo-Castro, Marta (Hospital Universitario Ramón y Cajal (Madrid)) ;
Ares, Jessica (Instituto de Investigación Sanitaria del Principado de Asturias) ;
Álvarez-Escola, Cristina (Hospital Universitario La Paz (Madrid)) ;
Vicente, Almudena (Hospital Universitario de Toledo) ;
Álvarez Guivernau, Èlia (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Novoa-Testa, Iria (Complejo Hospitalario Universitario de A Coruña) ;
Guerrero Perez, Fernando (Hospital Universitari de Bellvitge) ;
Cámara, Rosa (Hospital Universitari i Politècnic La Fe (València)) ;
Lecumberri, Beatriz (Hospital Universitario La Paz (Madrid)) ;
García Gómez, Carlos (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Bernabeu Morón, Ignacio (Instituto de Investigación Sanitaria de Santiago (IDIS)) ;
Manjón, Laura (Instituto de Investigación Sanitaria del Principado de Asturias) ;
Gaztambide, Sonia (Universidad del País Vasco) ;
Cordido, Fernando (Complejo Hospitalario Universitario de A Coruña) ;
Webb, S. M 1952- (Institut d'Investigació Biomèdica Sant Pau) ;
Menéndez Torre, E. (Instituto de Investigación Sanitaria del Principado de Asturias) ;
Díez, Juan J. (Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana) ;
Simó, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Puig-Domingo, Manel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
Context: Some reports suggest that acromegaly in elderly patients has a more benign clinical behavior and could have a better response to first-generation long-acting somatostatin receptor ligands (SRL). [...]
2022 - 10.3389/fendo.2022.984877
Frontiers in Endocrinology, Vol. 13 (September 2022) , p. 984877
|
|